Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00RGP
|
||||
Former ID |
DNC009503
|
||||
Drug Name |
MEDIORESINOL
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527404] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H24O7
|
||||
Canonical SMILES |
COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C=C4)O)OC
|
||||
InChI |
1S/C21H24O7/c1-24-16-6-11(4-5-15(16)22)20-13-9-28-21(14(13)10-27-20)12-7-17(25-2)19(23)18(8-12)26-3/h4-8,13-14,20-23H,9-10H2,1-3H3/t13-,14-,20+,21?/m0/s1
|
||||
InChIKey |
VJOBNGRIBLNUKN-ITZZLVQVSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 3A4 | Target Info | Inhibitor | [527404] | |
PathWhiz Pathway | Caffeine Metabolism | ||||
Retinol Metabolism | |||||
WikiPathways | Metapathway biotransformation | ||||
Aflatoxin B1 metabolism | |||||
Estrogen metabolism | |||||
Benzo(a)pyrene metabolism | |||||
Tamoxifen metabolism | |||||
Tryptophan metabolism | |||||
Oxidation by Cytochrome P450 | |||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Nuclear Receptors Meta-Pathway | |||||
Farnesoid X Receptor Pathway | |||||
Vitamin D Receptor Pathway | |||||
Felbamate Metabolism | |||||
Lidocaine metabolism | |||||
Nifedipine Activity | |||||
Colchicine Metabolic Pathway | |||||
Irinotecan Pathway | |||||
Drug Induction of Bile Acid Pathway | |||||
Fatty Acid Omega Oxidation | |||||
Codeine and Morphine Metabolism | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.